ALMANARA LIMITED

Company number 12614506 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ALMANARA LIMITED - Analysis Report

Company Number: 12614506

Analysis Date: 2025-07-20 16:16 UTC

Financial Health Assessment for ALMANARA LIMITED


1. Financial Health Score: D

Explanation:
The company shows signs of financial strain with recurring negative working capital and minimal net assets. Although it is not in immediate distress, the financial "vital signs" suggest limited liquidity and a fragile capital base. This score reflects the symptoms of a company struggling to maintain healthy cash flow and operational buffer, typical of early-stage or micro-entities facing funding or revenue challenges.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Fixed Assets 1,245 Minimal investment in long-term assets
Current Assets 8,958 Modest short-term resources available
Current Liabilities 10,065 Short-term debts slightly exceed assets
Net Current Assets -1,107 Negative working capital—"symptom of liquidity stress"
Total Net Assets 138 Very low equity base, marginally positive
Turnover Not reported Limited or no recent revenue reported
Share Capital 1 Nominal capital, typical for micro-entity
Average Employees 0 No staff employed, possibly subcontracted work or owner-managed

Interpretation:

  • The negative net current assets indicate the company’s current liabilities exceed its current assets, a "warning sign" of possible liquidity issues.
  • The very low net assets and shareholders’ funds suggest minimal financial cushion to absorb shocks or losses.
  • The absence of turnover data in the latest year and zero employees implies the company may be in a startup or holding phase, with limited trading activity.
  • The slight improvement from a negative net asset position in 2023 (£-21) to a positive but very low figure in 2024 (£138) indicates some progress but remains fragile.
  • The company operates as a micro-entity, which limits the complexity of reporting but also suggests a small scale of operations.

3. Diagnosis

Underlying Financial Health:
ALMANARA LIMITED’s financial condition resembles a patient with mild but persistent symptoms of financial stress. The key symptom of negative working capital signals that the company may struggle to meet short-term obligations without external support or improved cash inflows. The minimal net asset base reflects little retained earnings or capital reserves, which reduces resilience against business downturns or unexpected expenses.

The company is not currently in liquidation or administration, and filings are up to date, which indicates compliance and operational continuity. However, the lack of turnover data and zero employees suggest limited business activity or a very early-stage business model. This could be normal for a micro-entity in developmental stages but poses risks if sustained.

Risk Factors:

  • Liquidity risk due to negative net current assets.
  • Limited operational scale and financial buffer.
  • Reliance on directors/shareholders for capital infusion or operational funding.

4. Recommendations

Immediate Actions:

  • Improve Working Capital: Seek to increase current assets or reduce current liabilities. This could include faster collection of receivables, negotiating extended payment terms with suppliers, or injecting additional cash capital.
  • Enhance Revenue Streams: Review and implement strategies to generate consistent turnover, as the absence of revenue weakens financial health and sustainability.
  • Cost Management: Keep operating expenses minimal given zero employees, and avoid unnecessary liabilities.

Medium to Long-Term Actions:

  • Build Capital Reserves: Consider equity injections or retained earnings to strengthen shareholders’ funds and provide a financial cushion.
  • Financial Monitoring: Implement robust cash flow forecasting and financial controls to detect early symptoms of distress and respond proactively.
  • Business Development: Explore partnerships, marketing, or diversification to increase trading activity and improve business viability.

Governance and Compliance:

  • Maintain timely filings to avoid penalties and maintain good company standing.
  • Directors should monitor financial health regularly and consider professional advice if liquidity issues worsen.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.